北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学精神卫生研究所  > 期刊论文
学科主题: 精神卫生
题名:
Fluvoxamine in the treatment of depression: results from a Chinese population
作者: Gu, NF1; Cai, ZJ1; Liang, S1; Zhou, TX1; Xu, JM1; Zhang, XB1; Wu, WY1; Ming, L1
关键词: depression ; fluvoxamine ; selective serotonin reuptake inhibitor ; china
刊名: PRIMARY CARE PSYCHIATRY
发表日期: 2004
DOI: 10.1185/135525704X10746
卷: 9, 期:3, 页:89-94
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Medicine, General & Internal ; Psychiatry
研究领域[WOS]: General & Internal Medicine ; Psychiatry
关键词[WOS]: SEROTONIN TRANSPORTER GENE ; MAJOR DEPRESSION ; DOUBLE-BLIND ; MEDICAL OUTCOMES ; PAROXETINE ; OUTPATIENTS ; MANAGEMENT ; FLUOXETINE ; DISORDERS ; COMMUNITY
英文摘要:

This multicentre, open, post-marketing study was conducted to investigate the efficacy and tolerability of fluvoxamine in patients with depressive disorders in China. A total of 120 Chinese patients were treated with fluvoxamine (50 mg/day for one week followed by 100-150 mg/day) for 6 weeks. The majority of patients (76.7%) were stabilised on a dose of 100 mg/day for the duration of the study. There was a significant clinical response to fluvoxamine; more than 85% of patients were considered responders at the end of the study as assessed by their improvement on the Hamilton Depression Rating Scale (greater than or equal to50% reduction in score). These findings were confirmed by the Clinical Global Impression (CGI) - Severity scale, CGI Improvement scale and CGI - Quality of life scale. Fluvoxamine was well tolerated; the most common adverse events were dry mouth, nausea and vomiting, and constipation. In conclusion, fluvoxamine at a dose of 100-150 mg/day is effective, safe and well-tolerated in the treatment of people with depression.

语种: 英语
WOS记录号: WOS:000225872500004
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/51568
Appears in Collections:北京大学精神卫生研究所_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Suzhou Guangji Hosp, Suzhou, Peoples R China
2.Peking Univ, Inst Mental Hlth, Beijing, Peoples R China
3.Hongkou Dist Mental Hlth Ctr, Shanghai, Peoples R China
4.Nanjing Brain Hosp, Nanjing, Peoples R China
5.Shanghai Mental Hlth Ctr, Dept Psychiat, Shanghai 200030, Peoples R China
6.Capital Med Univ, Beijing Andling Hosp, Beijing, Peoples R China
7.Fudan Univ, Shanghai Zongshan Hosp, Shanghai 200433, Peoples R China
8.Tongji Univ, Shanghai Tongji Hosp, Mental & Somatol Dept, Shanghai 200092, Peoples R China

Recommended Citation:
Gu, NF,Cai, ZJ,Liang, S,et al. Fluvoxamine in the treatment of depression: results from a Chinese population[J]. PRIMARY CARE PSYCHIATRY,2004,9(3):89-94.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Gu, NF]'s Articles
[Cai, ZJ]'s Articles
[Liang, S]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Gu, NF]‘s Articles
[Cai, ZJ]‘s Articles
[Liang, S]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace